Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY:HLN)

9.185 -0.005 (-0.05%)
Streaming Delayed Price Updated: 3:25 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 Next >
3 cheap 'stock'-ing stuffers Wall Street is bullish on
These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders. 
Via MarketBeat
Topics Stocks
Health exclusion affects more than three in five people globally
From Haleon
Via GlobeNewswire
Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over... 
Via Benzinga
7 Healthcare Stocks to invest in for a Healthy Future
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners. 
Via InvestorPlace
Peering Into Haleon's Recent Short Interest
 
Via Benzinga
How Is The Market Feeling About Haleon?
 
Via Benzinga
P/E Ratio Insights for Haleon
 
Via Benzinga
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
Haleon Earnings Preview
 
Via Benzinga
Robitussin Recall 2024: What to Know About the New Cough Syrup Recalls
A Robitussin recall is underway for two of the company's products after discovering microbial contamination of its cough syrups. 
Via InvestorPlace
Robitussin Recall: Here Are The Products Impacted And What You Need To Know
Haleon PLC (NYSE: HLN) announced a product recall of some of its Robitussin brand cough syrups. What Happened: A microbial contamination in Robitussin cough syrups could potentially cause... 
Via Benzinga
GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
GSK sells 300M shares in Haleon at £326/share, raising £978M. GSK to retain 4.2% stake. 
Via Benzinga
Peering Into Haleon's Recent Short Interest
 
Via Benzinga
How Is The Market Feeling About Haleon?
 
Via Benzinga
Looking Into Haleon's Recent Short Interest
 
Via Benzinga
How Is The Market Feeling About Haleon?
 
Via Benzinga
A Look Into Haleon Inc's Price Over Earnings
 
Via Benzinga
How Is The Market Feeling About Haleon?
 
Via Benzinga
GSK: Pharma Giant Prioritizing Shareholder Dividends
A good hunting ground for dividend stocks is often companies from which Wall Street wants to see strong performance in the short-term, while its long-term prospects are actually what are most bright. 
Via Talk Markets
Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger 
Via Benzinga
GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
GSK Plc (NYSE: GSK) said it raised £885.6 million ( 
Via Benzinga
How Is The Market Feeling About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)?
 
Via Benzinga
Looking Into Haleon's Recent Short Interest
 
Via Benzinga
Haleon Lifts Annual Sales Forecasts, Says Pricing & Efficiencies Offset Inflationary Pressures
Haleon PLC (NYSE: HLN) reported  
Via Benzinga
P/E Ratio Insights for Haleon
 
Via Benzinga
Is GSK Stock Worth Buying Right Now?
GSK stock could be a bargain. 
Via The Motley Fool
New global study discovers people in pain feel more socially excluded than ever
From Haleon
Via GlobeNewswire
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
A Look Into Haleon Inc's Price Over Earnings
 
Via Benzinga
Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories
Reuters 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.